Skip to content

AORIF Complex Ankle Fractures

Arthroscopically Assisted Treatment of Complex Ankle Fractures - Intraarticular Findings and Prospective PROM Follow-Up

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04033848
Enrollment
100
Registered
2019-07-26
Start date
2013-05-01
Completion date
2021-05-31
Last updated
2019-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle Fractures

Keywords

Arthroscopy, Ankle Fracture, Patient rated outcome

Brief summary

The aim of this study is to evaluate the intraarticular lesions, to identify fractures specifically at risk for these, and to assess the results following arthroscopically assisted open reduction and internal fixation of complex ankle fractures prospectively.

Detailed description

Starting 05/01/13 patients with complex ankle fractures, older than 17 years, who sustained the injury less than 14 days before surgery and giving informed consent are consecutively enrolled. A complex fracture is defined as either an isolated malleolar fracture in combination with ligamentous instability, or a bi- or trimalleolar fracture. An unstable ligamentous injury is defined as either a disruption of the deltoid ligament leading to increased medial talar tilt, or an unstable syndesmotic injury assessed by the external rotation test both after osteosynthesis of all fractures. Exclusion criteria are isolated unimalleolar fractures, pilon fractures, open fractures, multiple injuries, mental illness, incompliance or pregnancy. Data assessed are: * Demographics * Medical history * Classification (AO, Haraguchi, ICRS, location and size defect) * Surgery details * Complications * PROMs (FAAM, AOFAS, OMAS, FAOS, TAS, SF-12, EQ-5d, MoxFQ)

Interventions

PROCEDUREArthroscopic assisted ankle fracture treatment

Any complex ankle fracture, as discriped above, will be treated arthroscopically and will be prospectively followed-up using well validated PROMs

Sponsors

Ludwig-Maximilians - University of Munich
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Unimalleolar fracture + ligamentous injury * Bi- or trimalleolar fracture ± ligamentous injury * \> 17 years * Date of injury less than 15 days * Written informed consent

Exclusion criteria

* Isolated unimalleolar fracture * Pilon fracture * Open fracture * Mental illness, incompliance, pregnancy * Multiple injuries

Design outcomes

Primary

MeasureTime frameDescription
OMASThrough study completion, an average of 1 yearOlerud and Molander Ankle Score; Validated PROM; Range 0-100

Secondary

MeasureTime frameDescription
FAAMThrough study completion, an average of 1 yearFoot and Ankle Ability Measure, Validated PROM; Range 0-100
AOFASThrough study completion, an average of 1 yearAmerican Orthopaedic Foot and Ankle Society, Validated PROM; Range 0-100
FAOSThrough study completion, an average of 1 yearFoot and Ankle Outcome Score, Validated PROM; Range 0-100
ICRS: Clinical Cartilage Injury Evaluation SystemIntraOPIntraarticular cartilage lesions and treatment
SF-12Through study completion, an average of 1 yearQuality of life score, Validated PROM; Range 0-100
EQ-5dThrough study completion, an average of 1 yearQuality of life score, Validated PROM; Range 0-100
MoxFQThrough study completion, an average of 1 yearThe Manchester-Oxford Foot Questionnaire, Validated PROM; Range 0-100
TASThrough study completion, an average of 1 yearTegener Activity Scale, Validated PROM; Range 0-10

Countries

Germany

Contacts

Primary ContactSebastian F Baumbach, MD
sebastian.baumbach@med.uni-muenchen.de0049894400
Backup ContactHans Polzer, MD
hans.polzer@med.uni-muenchen.de0049894400

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026